Julia Hoveyan: The first comprehensive analysis of pediatric and young adult CNS tumors in Armenia over the last 26 years.
Julia Hoveyan, Paediatric Oncologist at Paediatric Cancer and Blood Disorders Centre of Armenia, shared a post on LinkedIn:
“Exciting News!
After two years of dedicated research and hard work, I am thrilled to announce the publication of our paper titled “Trends in Paediatric CNS Tumors in Armenia: A Multicenter Retrospective Study” in the prestigious Child’s Nervous System Journal. This study marks the first comprehensive analysis of pediatric and young adult CNS tumors in Armenia over the last 26 years, providing crucial epidemiological insights along with vital information about diagnosis and treatment.
I had the incredible opportunity to present the abstract of this research at the SIOP Annual Congress in Ottawa, a milestone that became a reality thanks to the scholarship provided by St. Jude Global. This experience further emphasized the importance of international collaboration in advancing pediatric oncology research.
I would like to express my deepest gratitude to whole study team, to Immune Oncology Research Institute and St. Jude Children’s Research Hospital especially the amazing VPNOF team for their invaluable help and unwavering support throughout this journey. Special thanks to Samvel Bardakhchyan, Ibrahim Qaddoumi, Frederick Boop and Gevorg Tamamyan for their invaluable guidance and encouragement.
This achievement underscores the collaborative spirit and determination of our research team. Together, we are advancing knowledge in the field of pediatric oncology and making strides toward better outcomes for young patients.
I invite you to read the full paper in the Child’s Nervous System Journal to delve into the significant findings of our research. Thank you all for your support and encouragement.”
To read the paper click here.
Source: Julia Hoveyan/LinkedIn.
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:17 27/11Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows